Table 4: Projection of the proportion of ceftobiprole-susceptible isolates among microbiological aetiologies associated with HAP (excluding VAP)
Table 4: Projection of the proportion of ceftobiprole-susceptible isolates among microbiological aetiologies associated with HAP (excluding VAP)